Acquisition by Wilson William R Jr. of 4750 shares of Genprex subject to Rule 16b-3
| GNPX Stock | USD 1.16 0.10 9.43% |
Slightly above 57% of all Genprex's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Genprex suggests that some traders are interested. Genprex's investing sentiment can be driven by a variety of factors including economic data, Genprex's earnings reports, geopolitical events, and overall market trends.
Genprex |
Filed transaction by Genprex Director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Genprex Fundamental Analysis
We analyze Genprex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genprex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genprex based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Genprex is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Genprex Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genprex stock to make a market-neutral strategy. Peer analysis of Genprex could also be used in its relative valuation, which is a method of valuing Genprex by comparing valuation metrics with similar companies.
Peers
Genprex Related Equities
| XFOR | X4 Pharmaceuticals | 11.67 | ||||
| RNAZ | Transcode Therapeutics | 2.91 | ||||
| GLSI | Greenwich Lifesciences | 2.27 | ||||
| KOD | Kodiak Sciences | 1.19 | ||||
| MREO | Mereo BioPharma | 0.27 | ||||
| ELEV | Elevation Oncology | 4.48 | ||||
| HEPA | Hepion Pharmaceuticals | 4.84 | ||||
| RVPH | Reviva Pharmaceuticals | 5.78 | ||||
| CGTX | Cognition Therapeutics | 5.88 | ||||
| RVPHW | Reviva Pharmaceuticals | 11.43 |
Additional Tools for Genprex Stock Analysis
When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.